We’re excited to announce $35 million in funding, including a $25 million Series B led by Felicis Ventures, and a previously-unannounced $10 million Series A led by Amplify Partners, which also participated in the Series B.
The investment will help us expand our work to give patients control of their medical data and ensure they are real partners in advancing scientific research. You can read the press release here.